(HealthDay)—Mavenclad (cladribine) tablets were approved to treat adult patients with relapsing-remitting and active secondary progressive multiple sclerosis (MS) who have inadequately responded to or cannot tolerate an ...
Apr 2, 2019
0
1
There's good news for women with multiple sclerosis (MS)—researchers now say the disease may not flare up again right after pregnancy as they had long believed, according to a preliminary study released today that will ...
Mar 7, 2019
0
1
A molecular epigenetic marker is important for distinguishing patients with childhood leukaemia at high and low risk of relapse even at the time of diagnosis. It can be important to adapt early on as to what treatment to ...
Mar 7, 2019
0
1
Combining certain types of two antipsychotic agents in the maintenance treatment of schizophrenia is associated with a lower risk of relapse than using monotherapy. This is suggested in a paper published by researchers at ...
Feb 21, 2019
0
70
Vivid dreams involving drinking and drug use are common among individuals in recovery. A study from the Massachusetts General Hospital (MGH) Recovery Research Institute, published in the January issue of the Journal of Substance ...
Feb 13, 2019
0
2
(HealthDay)—For patients with relapsing-remitting multiple sclerosis (MS), nonmyeloablative hematopoietic stem cell transplantation (HCST) is associated with prolonged time to disease progression compared with disease-modifying ...
Jan 16, 2019
0
1
Predicting who will remain drug-free and who will relapse following treatment for drug addiction has been impossible – so far. Now, Stanford psychologists think they've found a possible clue. For stimulants like cocaine ...
Jan 2, 2019
0
61
Smokers who switch to vaping don't lapse for long—according to new research from the University of East Anglia.
Nov 28, 2018
0
45
(HealthDay)—Rates of multiple sclerosis (MS) relapse decrease during pregnancy but increase postpartum, according to a study published online Oct. 23 in Neurology.
Nov 20, 2018
0
2
Doctoral research by Annemieke Witteveen at the University of Twente has shown that the number of follow-up visits for women after breast cancer treatment in the Netherlands could be reduced by about 9,000 visits per year. ...
Nov 8, 2018
0
0
